Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study.

PubWeight™: 3.40‹?› | Rank: Top 1%

🔗 View Article (PMC 3898949)

Published in Lancet on September 20, 2013

Authors

Matthew Cotten1, Simon J Watson1, Paul Kellam2, Abdullah A Al-Rabeeah3, Hatem Q Makhdoom4, Abdullah Assiri3, Jaffar A Al-Tawfiq5, Rafat F Alhakeem3, Hossam Madani4, Fahad A AlRabiah6, Sami Al Hajjar6, Wafa N Al-nassir7, Ali Albarrak8, Hesham Flemban9, Hanan H Balkhy10, Sarah Alsubaie11, Anne L Palser1, Astrid Gall1, Rachael Bashford-Rogers1, Andrew Rambaut12, Alimuddin I Zumla13, Ziad A Memish14

Author Affiliations

1: Wellcome Trust Sanger Institute, Hinxton, UK.
2: Wellcome Trust Sanger Institute, Hinxton, UK; Division of Infection and Immunity, University College London, London, UK.
3: Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.
4: Jeddah Regional Laboratory, Ministry of Health, Jeddah, Saudi Arabia.
5: Saudi Aramco Medical Services Organisation, Saudi Aramco, Dhahran, Saudi Arabia.
6: King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
7: Imam Abdulrahman Bin Mohamed Hospital-National Guard Health Affairs-Dammam, Saudi Arabia.
8: Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
9: Alhada Military Hospital, Riyadh, Saudi Arabia.
10: King Abdulaziz Medical City, Riyadh, Saudi Arabia.
11: Paediatric Infectious Diseases, King Saud University, Saudi Arabia.
12: Institute of Evolutionary Biology, Ashworth Laboratories, Kings Buildings, West Mains Road, Edinburgh, UK; Fogarty International Center, NIH, Bethesda, MD, USA.
13: Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia; Division of Infection and Immunity, University College London, London, UK; UCL Hospitals NHS Foundation Trust, London, UK.
14: Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia. Electronic address: zmemish@yahoo.com.

Articles citing this

Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis (2014) 3.74

MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis (2014) 3.64

Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio (2014) 3.49

State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans. PLoS Curr (2013) 3.41

Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis (2013) 3.30

Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. MBio (2014) 2.50

Middle East respiratory syndrome coronavirus: epidemiology and disease control measures. Infect Drug Resist (2014) 1.91

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proc Natl Acad Sci U S A (2015) 1.64

Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev (2015) 1.64

Synthesizing data and models for the spread of MERS-CoV, 2013: key role of index cases and hospital transmission. Epidemics (2014) 1.60

A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Sci Transl Med (2015) 1.54

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution. Proc Natl Acad Sci U S A (2014) 1.54

Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J Virol (2014) 1.52

Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4. J Virol (2014) 1.31

Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med (2015) 1.29

NCBI viral genomes resource. Nucleic Acids Res (2014) 1.26

Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study. Int J Infect Dis (2014) 1.26

Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection. J Virol (2014) 1.25

MERS: emergence of a novel human coronavirus. Curr Opin Virol (2014) 1.22

Molecular Epidemiology of Hospital Outbreak of Middle East Respiratory Syndrome, Riyadh, Saudi Arabia, 2014. Emerg Infect Dis (2015) 1.14

The emergence of the Middle East respiratory syndrome coronavirus. Pathog Dis (2014) 1.14

Microevolution of Outbreak-Associated Middle East Respiratory Syndrome Coronavirus, South Korea, 2015. Emerg Infect Dis (2016) 1.01

MERS coronavirus: diagnostics, epidemiology and transmission. Virol J (2015) 1.01

Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov (2016) 0.91

Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis). Sci Rep (2016) 0.91

Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus. J Virol (2014) 0.89

A Sweet Spot for Molecular Diagnostics: Coupling Isothermal Amplification and Strand Exchange Circuits to Glucometers. Sci Rep (2015) 0.86

Deletion Variants of Middle East Respiratory Syndrome Coronavirus from Humans, Jordan, 2015. Emerg Infect Dis (2016) 0.86

Local evolutionary patterns of human respiratory syncytial virus derived from whole-genome sequencing. J Virol (2015) 0.85

Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV). PLoS One (2015) 0.83

Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS. J Biol Chem (2015) 0.82

Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi. Emerg Infect Dis (2016) 0.82

MERS-CoV recombination: implications about the reservoir and potential for adaptation. Virus Evol (2016) 0.81

The recent ancestry of Middle East respiratory syndrome coronavirus in Korea has been shaped by recombination. Sci Rep (2016) 0.81

Unanswered questions about the Middle East respiratory syndrome coronavirus (MERS-CoV). BMC Res Notes (2014) 0.80

A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses. J Virol (2014) 0.80

Middle East respiratory syndrome: obstacles and prospects for vaccine development. Expert Rev Vaccines (2015) 0.80

Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates. BMC Genomics (2014) 0.79

Evolutionary Dynamics of MERS-CoV: Potential Recombination, Positive Selection and Transmission. Sci Rep (2016) 0.77

A scenario-based evaluation of the Middle East respiratory syndrome coronavirus and the Hajj. Risk Anal (2014) 0.77

Isolation of Middle East Respiratory Syndrome Coronavirus from a Patient of the 2015 Korean Outbreak. J Korean Med Sci (2016) 0.77

Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection. Antiviral Res (2016) 0.77

Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection. Sci Rep (2016) 0.76

Population viscosity suppresses disease emergence by preserving local herd immunity. Proc Biol Sci (2014) 0.76

Phylogenetic Exploration of Nosocomial Transmission Chains of 2009 Influenza A/H1N1 among Children Admitted at Red Cross War Memorial Children's Hospital, Cape Town, South Africa in 2011. PLoS One (2015) 0.75

Estimating infectious disease transmission distances using the overall distribution of cases. Epidemics (2016) 0.75

Polyphyletic origin of MERS coronaviruses and isolation of a novel clade A strain from dromedary camels in the United Arab Emirates. Emerg Microbes Infect (2016) 0.75

Transmission patterns and evolution of respiratory syncytial virus in a community outbreak identified by genomic analysis. Virus Evol (2017) 0.75

Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study. BMC Infect Dis (2017) 0.75

Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus. Cold Spring Harb Mol Case Stud (2016) 0.75

K-Pax2: Bayesian identification of cluster-defining amino acid positions in large sequence datasets. Microb Genom (2015) 0.75

Silent War to Emerging or Re-emerging Respiratory Infection Diseases Badly Kept in Mind. Chin Med J (Engl) (2015) 0.75

10 years later... Can J Infect Dis Med Microbiol (2013) 0.75

Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci Rep (2016) 0.75

Knowledge and Apprehension of Dental Patients about MERS-A Questionnaire Survey. J Clin Diagn Res (2016) 0.75

Tracking the transmission and evolution of MERS-CoV. Lancet (2013) 0.75

Middle East respiratory syndrome coronavirus: review of the current situation in the world. Disaster Mil Med (2016) 0.75

Two deletion variants of Middle East respiratory syndrome coronavirus found in a patient with characteristic symptoms. Arch Virol (2017) 0.75

Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein. Proc Natl Acad Sci U S A (2017) 0.75

Articles cited by this

MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97

MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics (2001) 101.31

SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol (2012) 62.36

Relaxed phylogenetics and dating with confidence. PLoS Biol (2006) 37.68

Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol (2012) 32.00

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med (2012) 22.75

HyPhy: hypothesis testing using phylogenies. Bioinformatics (2004) 17.33

Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med (2013) 11.85

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio (2012) 8.54

Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill (2012) 7.96

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis (2013) 7.83

Smooth skyride through a rough skyline: Bayesian coalescent-based inference of population dynamics. Mol Biol Evol (2008) 6.52

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39

Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics (2010) 6.14

Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill (2012) 4.95

Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis (2013) 4.78

Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med (2013) 4.66

Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet (2013) 4.16

Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis (2013) 3.61

Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci U S A (2005) 3.37

Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus. Emerg Infect Dis (2013) 3.35

Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J (2005) 3.14

Prediction of proprotein convertase cleavage sites. Protein Eng Des Sel (2004) 3.05

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature (2013) 3.00

Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol (2006) 2.80

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A (2009) 1.83

Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium. J Virol (2007) 1.52

Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome. Lancet (2004) 1.51

Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol (2010) 1.44

Recovery from severe novel coronavirus infection. Saudi Med J (2012) 1.19